Smart Nuclide Pharmaceutical Technology

China-based Tot Biopharmaceutical International Co., Ltd (HKG: 1875) has announced a strategic partnership with Suzhou Smart Nuclide Pharmaceutical Technology Company, a move focused on the development of radioactive drugs based on conjugate technology. Complementary Expertise in RadiopharmaceuticalsUnder the terms of the partnership, Tot Bio will offer a comprehensive antibody conjugate…